SHEA GUIDELINES Bundle (free trial)

C diff

SHEA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1524017

Contents of this Issue

Navigation

Page 10 of 15

11 Comments Implementation depends upon available resources. Vancomycin remains an acceptable alternative. Definition of nonsevere CDI is supported by the following laboratory parameters: White blood cell count of 15 000 cells/μL or lower and a serum creatinine level <1.5 mg/dL Tapered/pulsed vancomycin regimen example: 125 mg 4 times daily for 10–14 days, 2 times daily for 7 days, once daily for 7 days, and then every 2 to 3 days for 2 to 8 weeks Consider a standard course of vancomycin if metronidazole was used for treatment of the first episode Data when combined with fidaxomicin are limited. Caution for use in patients with congestive heart failure b e opinion of the panel is that appropriate antibiotic treatments for at least 2 recurrences (ie, 3 CDI episodes) should be tried prior to offering fecal microbiota transplantation Data when combined with fidaxomicin are limited. Caution for use in patients with congestive heart failure a Definition of fulminant CDI is supported by: Hypotension or shock, ileus, megacolon

Articles in this issue

Archives of this issue

view archives of SHEA GUIDELINES Bundle (free trial) - C diff